Sudan Loganathan Stock Analyst Profile - Stephens & Co. Research Coverage - Stocknear

Sudan Loganathan

Stock Analyst at Stephens & Co.

(3.48)
# 2690
Out of 5,506 analysts
43
Total ratings
Success rate
Average return
Main Sectors:

17 Stocks

Name Action PT Current % Upside Ratings Updated
CCCC C4 Therapeutics
Reiterates: Overweight
6 6
2.27 164.32% 3 Sep 22, 2025
ARVN Arvinas
Maintains: Overweight
16 14
9.61 45.68% 2 Sep 18, 2025
IDYA IDEAYA Biosciences
Reiterates: Overweight
45 45
27.64 62.81% 3 Sep 9, 2025
NRIX Nurix Therapeutics
Reiterates: Overweight
30 30
9.38 219.83% 4 Jul 10, 2025
EXEL Exelixis
Upgrades: Overweight
29 60
40.09 49.66% 5 Jun 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
25 25
11.1 125.23% 3 Jun 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
150 135
n/a n/a 3 Jun 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
5 5
n/a n/a 4 Mar 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
30 30
12.38 142.33% 2 Mar 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
33 33
20.84 58.35% 2 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
6 8
4.08 96.08% 2 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
15 15
8.37 79.21% 2 Jan 22, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
60 60
57.9 3.63% 2 Jan 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
5 5
1.57 218.47% 2 Nov 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
13
2.57 405.84% 1 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
100 100
9.31 974.11% 2 May 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
20
2.43 723.05% 1 May 14, 2024